Company · CIK 0001815260
Athyrium Opportunities III Co-Invest 1 LP
other
Exchange
—
Entity type
other
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SCHEDULE 13D/ABIORA THERAPEUTICS, INC.0000950170-25-045642 · 19.8 KBSEC(opens sec.gov)
Insiders
No insiders on record.
Tickers
No tickers on record.
Addresses
business
505 FIFTH AVENUE, FLOOR 18
NEW YORK, NY, 10017
mailing
505 FIFTH AVENUE, FLOOR 18
NEW YORK, NY, 10017